MIST Logo

Milestone Pharmaceuticals Inc. (MIST) 

NASDAQ
Market Cap
$94.55M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
621 of 776
Rank in Industry
336 of 433

Largest Insider Buys in Sector

MIST Stock Price History Chart

MIST Stock Performance

About Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil …

Insider Activity of Milestone Pharmaceuticals Inc.

Over the last 12 months, insiders at Milestone Pharmaceuticals Inc. have bought $0 and sold $0 worth of Milestone Pharmaceuticals Inc. stock.

On average, over the past 5 years, insiders at Milestone Pharmaceuticals Inc. have bought $8.88M and sold $10.86M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 7,000 shares for transaction amount of $32,830 was made by Bharucha David (Chief Medical Officer) on 2022‑12‑05.

List of Insider Buy and Sell Transactions, Milestone Pharmaceuticals Inc.

2022-12-05PurchaseChief Medical Officer
7,000
0.0162%
$4.69$32,830-27.47%
2022-12-01PurchaseChief Medical Officer
3,000
0.007%
$4.86$14,580-29.01%
2022-10-21Purchasedirector
4,000
0.0096%
$5.26$21,040-28.57%
2022-10-20Purchasedirector
10,000
0.0232%
$5.20$52,000-30.21%
2022-10-20Purchasedirector
10,000
0.0236%
$5.29$52,900-30.21%
2022-10-19Purchasedirector
15,000
0.0349%
$4.93$73,950-26.01%
2022-10-19Purchasedirector
15,000
0.0376%
$5.32$79,800-26.01%
2022-09-07Sale
1.56M
3.6651%
$8.71$13.56M-56.03%
2022-09-07Purchase
1.56M
3.6651%
$8.71$13.56M-56.03%
2022-05-31Purchase
5,000
0.0118%
$5.60$28,000-19.25%
2020-07-29Sale10 percent owner
500,000
1.5968%
$8.32$4.16M-22.80%
2020-07-28Sale10 percent owner
19,863
0.0675%
$8.10$160,890-15.61%
2020-03-19Purchase10 percent owner
5,870
0.02%
$10.87$63,804-47.34%
2020-03-18Purchase10 percent owner
2,705
0.0091%
$10.36$28,029-45.49%
2020-03-02Purchase10 percent owner
78,263
0.3217%
$18.95$1.48M-63.55%
2020-01-13Purchase10 percent owner
270,000
1.0575%
$16.25$4.39M-59.47%
2019-12-31Purchasedirector
21,438
0.0846%
$15.50$332,340-56.84%
2019-12-30Purchasedirector
1,333
0.0054%
$15.48$20,638-55.51%
2019-11-25Sale10 percent owner
240,000
0.8778%
$16.00$3.84M-57.86%
2019-11-20Purchase10 percent owner
400,000
1.4001%
$16.00$6.4M-58.59%

Insider Historical Profitability

<0.0001%
RTW INVESTMENTS, LP10 percent owner
4315102
8.1005%
$1.78130
WONG RODERICK
4315102
8.1005%
$1.7811<0.0001%
Novo Holdings A/S10 percent owner
2434470
4.5701%
$1.7811
BDC CAPITAL INC.10 percent owner
2388088
4.483%
$1.7810
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC10 percent owner
2254920
4.233%
$1.7812

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$8.9M9.334.97M+51.99%+$3.04M<0.0001
RTW Investments, LP$5.83M6.113.26M0%+$00.09
Millennium Management LLC$5.11M5.362.86M+91.08%+$2.44M<0.01
Alta Fundamental Advisers Llc$4.24M4.452.37M+41.88%+$1.25M2.2
Lion Point Capital LP$4.12M4.322.3M+39.39%+$1.16M7.98
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.